Cahill Gordon & Reindel LLP
80 Pine Street
New York, NY 10005-1702
Lauren Rackow is Counsel at Cahill Gordon & Reindel LLP. Her practice is focused on a wide range of antitrust matters, advising and representing clients on mergers and acquisitions, complex antitrust litigation, government investigations, financing transactions with the potential for antitrust risk, and antitrust compliance.
Most recently, Lauren has advised Tembec Inc. with its prospective acquisition by Rayonier Advanced Materials Inc., Arch Capital Group Ltd. with its acquisition of United Guaranty Corporation, The Empire District Electric Company in an acquisition by Algonquin Power & Utilities Corp., Coca-Cola Enterprises in its merger with Coca-Cola Iberian Partners and Coca-Cola Erfrischungsgetränk, ICON plc in numerous acquisitions, including the company’s acquisition of MediMedia Pharma Solutions and Aptiv Solutions, and 1-800-Flowers.COM, Inc. in their sale of Fannie May Confections Brands, Inc. and acquisition of specialty retailer Harry & David. Lauren also acts as antitrust counsel to the financing sources in many major acquisitions featuring significant debt financings, including some of the largest buyouts completed in U.S. history, as well as many other significant mergers and acquisitions. On the litigation and investigations side, Lauren has most recently represented Credit Suisse and its subsidiaries in all U.S. litigation relating to the alleged manipulation of the US Dollar and CHF London Inter-Bank Offered Rate.
Lauren is recognized as a Future Leader in The International Who's Who of Competition Lawyers.
Lauren writes and speaks frequently on antitrust topics and is active in the American Bar Association Section of Antitrust Law, where she serves as Vice-Chair of the Health Care & Pharmaceuticals Committee, and the New York State Bar Association Antirust Law Section, where she serves as a member of the Executive Committee. Lauren has moderated and participated in panels on a variety of topics, such as reverse payments in settlements of patent litigation at the American Bar Association Section of Antitrust Law Spring Meeting (2017), two-sided markets (2016), remedies in pharmaceutical mergers (2015), pre-merger integration planning (2015), the rule of reason in horizontal restraints (2014), remedies in hospital mergers (2014), and pharmaceutical fundamentals (2013).